Crystal structure of oxibendazole, C12H15N3O3

被引:0
|
作者
Kaduk, James A. A. [1 ,2 ]
Gates-Rector, Stacy [3 ]
Blanton, Thomas N. N. [3 ]
机构
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
关键词
oxibendazole; Loditac; powder diffraction; Rietveld refinement; density functional theory; POWDER; VALIDATION; PATTERNS; DENSITY;
D O I
10.1017/S0885715622000495
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The crystal structure of oxibendazole has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Oxibendazole crystallizes in space group C2/c (#15) with a = 23.18673(22), b = 5.35136(5), c = 19.88932(13) angstrom, beta = 97.0876(9)degrees, V = 2449.018(17) angstrom(3), and Z = 8. The structure consists of hydrogen-bonded layers of planar molecules parallel to the bc-plane. Strong N-HMIDLINE HORIZONTAL ELLIPSISN hydrogen bonds link the molecules into dimers, with a graph set R2,2(8). N-HMIDLINE HORIZONTAL ELLIPSISO hydrogen bonds further link these dimers into layers parallel to the bc-plane. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File (TM) (PDF (R)).
引用
收藏
页码:15 / 20
页数:6
相关论文
共 50 条
  • [41] Crystal structure of sparsentan, C32H40N4O5S
    Kaduk, James A.
    Dosen, Anja
    Blanton, Thomas
    POWDER DIFFRACTION, 2025,
  • [42] Crystal Structure of Fosfomycin Tromethamine, (C4H12NO3)(C3H6O4P), from Synchrotron Powder Diffraction Data and Density Functional Theory
    Butler, Zachary R.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    CRYSTALS, 2019, 9 (08):
  • [43] Crystal structure of haloxon, C14H14Cl3O6P
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (04) : 235 - 239
  • [44] Crystal structure of sitagliptin dihydrogen phosphate monohydrate, C16H16F6N5O(H2PO4)(H2O)
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2015, 30 (04) : 349 - 356
  • [45] Crystal structure of mupirocin form I, C26H44O9
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2016, 31 (02) : 118 - 125
  • [46] Crystal structure of tofacitinib dihydrogen citrate (Xeljanz®), (C16H21N6O) (H2C6H5O7)
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2021, 36 (02) : 92 - 99
  • [47] Crystal structure of ceftriaxone sodium hemiheptahydrate, C18H16N8O7S3Na2(H2O)3.5
    Gonzalez, Diana
    Golab, Joseph T.
    Eilert, Jan Y.
    Wang, Rong
    Kaduk, James A.
    POWDER DIFFRACTION, 2020, 35 (03) : 206 - 212
  • [48] Crystal structure of methylprednisolone acetate form II, C24H32O6
    Wheatley, Austin M.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2018, 33 (01) : 44 - 48
  • [49] Crystal structure of raltegravir potassium, C20H20FKN6O5
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2015, 30 (03) : 263 - 269
  • [50] Crystal structure of N-benzyl-N-nicotinoyl-nicotine amide C19H15N3O2
    Hosten, Eric C.
    Betz, Richard
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2021, 236 (01): : 101 - 103